Krajnc N, Itariu B, Macher S, Marik W, Harreiter J, Michl M, Novak K, Wober C, Pemp B, Bsteh G (2023) Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
Your surgical team should receive complete information about your GLP-1 therapy, dosage, and medication schedule
Am I a candidate for GLP-1 therapy
"You can't think of this only as medication" Kaganoff said
Editado por: Silvia Pellitero-Rodrguez - University Hospital Germans Trias i Pujol Badalona Federico Vzquez Sanmiguel - University Hospital Germans Trias i Pujol Badalona ltima actualizacin : Octubre 2025 La molcula del pptido anlogo al glucagn tipo1 (GLP-1) ha emergido, merced a la bioingeniera bioqumica, como un elemento esencial en el desarrollo de agonistas y multiagonistas basados en su estructura para el tratamiento de la obesidad